Non-Analgesic Symptomatic or Disease-Modifying Potential of TRPA1
- PMID: 31547502
- PMCID: PMC6836032
- DOI: 10.3390/medsci7100099
Non-Analgesic Symptomatic or Disease-Modifying Potential of TRPA1
Abstract
TRPA1, a versatile ion channel of the Transient Receptor Potential (TRP) channel family, detects a large variety of chemicals and can contribute to signal processing of other stimuli, e.g., due to its sensitivity to cytosolic calcium elevation or phosphoinositolphosphate modulation. At first, TRPA1 was found on sensory neurons, where it can act as a sensor for potential or actual tissue damage that ultimately may elicit pain or itch as warning symptoms. This review provides an update regarding the analgesic and antipruritic potential of TRPA1 modulation and the respective clinical trials. Furthermore, TRPA1 has been found in an increasing amount of other cell types. Therefore, the main focus of the review is to discuss the non-analgesic and particularly the disease-modifying potential of TRPA1. This includes diseases of the respiratory system, cancer, ischemia, allergy, diabetes, and the gastrointestinal system. The involvement of TRPA1 in the respective pathophysiological cascades is so far mainly based on pre-clinical data.
Keywords: clinical study; drug development; ion channel; itch; pain; pharmacology; therapy.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
TRPA1 antagonists as potential analgesic drugs.Pharmacol Ther. 2012 Feb;133(2):189-204. doi: 10.1016/j.pharmthera.2011.10.008. Epub 2011 Nov 15. Pharmacol Ther. 2012. PMID: 22119554 Review.
-
TRPA1 as a promising target in ischemia/reperfusion: A comprehensive review.Iran J Basic Med Sci. 2024;27(3):270-278. doi: 10.22038/IJBMS.2023.74590.16198. Iran J Basic Med Sci. 2024. PMID: 38333756 Free PMC article. Review.
-
Lysophosphatidic acid-induced itch is mediated by signalling of LPA5 receptor, phospholipase D and TRPA1/TRPV1.J Physiol. 2017 Apr 15;595(8):2681-2698. doi: 10.1113/JP273961. Epub 2017 Mar 22. J Physiol. 2017. PMID: 28176353 Free PMC article.
-
Transient receptor potential ankyrin 1 (TRPA1) ion channel in the pathophysiology of peripheral diabetic neuropathy.Scand J Pain. 2013 Jul 1;4(3):129-136. doi: 10.1016/j.sjpain.2012.11.001. Scand J Pain. 2013. PMID: 29913916
-
[Activation and regulation of nociceptive transient receptor potential (TRP) channels, TRPV1 and TRPA1].Yakugaku Zasshi. 2010 Mar;130(3):289-94. doi: 10.1248/yakushi.130.289. Yakugaku Zasshi. 2010. PMID: 20190512 Review. Japanese.
Cited by
-
Angiotensin Type 2 Receptors: Painful, or Not?Front Pharmacol. 2020 Dec 23;11:571994. doi: 10.3389/fphar.2020.571994. eCollection 2020. Front Pharmacol. 2020. PMID: 33424587 Free PMC article. Review.
-
Novel Analgesics with Peripheral Targets.Neurotherapeutics. 2020 Jul;17(3):784-825. doi: 10.1007/s13311-020-00937-z. Epub 2020 Oct 15. Neurotherapeutics. 2020. PMID: 33063247 Free PMC article. Review.
-
A Comprehensive Review on the Regulatory Action of TRP Channels: A Potential Therapeutic Target for Nociceptive Pain.Neurosci Insights. 2023 Dec 24;18:26331055231220340. doi: 10.1177/26331055231220340. eCollection 2023. Neurosci Insights. 2023. PMID: 38146332 Free PMC article. Review.
-
TRPA1-dependent and -independent activation by commonly used preservatives.Front Pharmacol. 2023 Oct 4;14:1248558. doi: 10.3389/fphar.2023.1248558. eCollection 2023. Front Pharmacol. 2023. PMID: 37860113 Free PMC article.
-
Nobel somatosensations and pain.Pflugers Arch. 2022 Apr;474(4):405-420. doi: 10.1007/s00424-022-02667-x. Epub 2022 Feb 14. Pflugers Arch. 2022. PMID: 35157132 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials